Compare Bilibili Inc (BILI) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bilibili Inc vs Stryker Corporation — how do they compare? Bilibili Inc trades at $18.35 (market cap $7.35B), while Stryker Corporation trades at $315.91 (market cap $119.25B). The key difference: Stryker Corporation is far larger — about 16.2× Bilibili Inc's market cap, and Stryker Corporation pays a 1.13% dividend while Bilibili Inc pays none. Which is the better fit depends on your goals.
| BILI | SYK | |
|---|---|---|
Market Cap | $7.35B | $119.25B |
Sector | Media | Technology |
52-Week High | $35.92 | $403.53 |
52-Week Low | $15.96 | $282.58 |
Enterprise Value | $5.20B | $131.01B |
Dividend Yield | — | 1.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bilibili (BILI) trades at $17.59, down 0.62% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q1 2026 EPS of $0.19, beating expectations, and maintains strong analyst support with 83.3% buy ratings. Revenue growth is steady, projected at $30.8B for 2026, with improving net income margins. Recent news highlights a new $300 million share repurchase program, signaling confidence in long-term value.
The outlook for BILI is cautiously optimistic, driven by earnings beats and shareholder-friendly actions, but risks include competitive pressures in the Chinese digital media space and technical bearishness. Upside potential hinges on sustained user growth and margin expansion, while volatility from market sentiment poses a near-term challenge.
Stryker (SYK) trades at $331.45, up 0.51% today, with strong analyst support (74% buy ratings) and a consensus price target of $388.44. The stock shows bullish technical signals despite a recent Q1 2026 earnings miss attributed to a temporary cyber disruption. Fundamentals remain solid with 2025 revenue of $25.12B, net income margin of 13.21%, and robust cash flow generation of $5.04B from operations.
Outlook remains positive with maintained full-year guidance and healthy end-market demand. Investment opportunity lies in the valuation discount to historical averages and innovation-driven growth. Key risks include cybersecurity vulnerabilities and competitive pressures in the medtech sector. The stock offers potential upside of 17% to consensus target with dividend stability as a Dividend Aristocrat.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bilibili Inc
Bilibili is a leading video sharing and online entertainment platform for Gen Z in China. It offers a diverse range of content, including anime, games, and live broadcasting, fueled by a highly engaged community.
Read more on BILI →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
